Bennett C Frank's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Sep 2, 2026
- Accession no.
- 0000874015-26-000262
- Filed
- Sep 2, 2026, 8:32 PM ET
- Trade date
- Aug 31, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bennett C FrankCIK 0001073387 | Officer (EVP, Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | JOtherAcquired | +110 | $51.31 | +$5,643.66 | 60,128 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.